nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunitrazepam—CYP1A2—chronic obstructive pulmonary disease	0.335	1	CbGaD
Flunitrazepam—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.0729	0.143	CbGbCtD
Flunitrazepam—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.0729	0.143	CbGbCtD
Flunitrazepam—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0552	0.109	CbGbCtD
Flunitrazepam—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0409	0.0805	CbGbCtD
Flunitrazepam—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0324	0.0638	CbGbCtD
Flunitrazepam—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0301	0.0593	CbGbCtD
Flunitrazepam—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0301	0.0593	CbGbCtD
Flunitrazepam—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0251	0.0493	CbGbCtD
Flunitrazepam—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0251	0.0493	CbGbCtD
Flunitrazepam—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0236	0.0466	CbGbCtD
Flunitrazepam—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0192	0.0378	CbGbCtD
Flunitrazepam—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.019	0.0374	CbGbCtD
Flunitrazepam—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.013	0.0256	CbGbCtD
Flunitrazepam—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0127	0.0249	CbGbCtD
Flunitrazepam—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0124	0.0244	CbGbCtD
Flunitrazepam—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.011	0.0217	CbGbCtD
Flunitrazepam—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00648	0.0128	CbGbCtD
Flunitrazepam—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00612	0.012	CbGbCtD
Flunitrazepam—Emotional distress—Salbutamol—chronic obstructive pulmonary disease	0.00286	0.0368	CcSEcCtD
Flunitrazepam—Sleep disturbance—Formoterol—chronic obstructive pulmonary disease	0.0023	0.0296	CcSEcCtD
Flunitrazepam—Sleep disturbance—Arformoterol—chronic obstructive pulmonary disease	0.0023	0.0296	CcSEcCtD
Flunitrazepam—Aggression—Montelukast—chronic obstructive pulmonary disease	0.00144	0.0185	CcSEcCtD
Flunitrazepam—Aggression—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.0178	CcSEcCtD
Flunitrazepam—Disorientation—Aminophylline—chronic obstructive pulmonary disease	0.00137	0.0177	CcSEcCtD
Flunitrazepam—Nightmare—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.0151	CcSEcCtD
Flunitrazepam—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.00117	0.0151	CcSEcCtD
Flunitrazepam—Sleep disorder—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.0139	CcSEcCtD
Flunitrazepam—Sleep disorder—Formoterol—chronic obstructive pulmonary disease	0.00108	0.0139	CcSEcCtD
Flunitrazepam—Sleep disorder—Montelukast—chronic obstructive pulmonary disease	0.00106	0.0136	CcSEcCtD
Flunitrazepam—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00104	0.0134	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.00103	0.0132	CcSEcCtD
Flunitrazepam—Disorientation—Montelukast—chronic obstructive pulmonary disease	0.00102	0.0132	CcSEcCtD
Flunitrazepam—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.013	CcSEcCtD
Flunitrazepam—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.001	0.0129	CcSEcCtD
Flunitrazepam—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.000942	0.0121	CcSEcCtD
Flunitrazepam—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000934	0.012	CcSEcCtD
Flunitrazepam—Irritability—Montelukast—chronic obstructive pulmonary disease	0.000874	0.0112	CcSEcCtD
Flunitrazepam—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.000843	0.0108	CcSEcCtD
Flunitrazepam—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.00083	0.0107	CcSEcCtD
Flunitrazepam—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000781	0.01	CcSEcCtD
Flunitrazepam—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000746	0.0096	CcSEcCtD
Flunitrazepam—Delusion—Prednisone—chronic obstructive pulmonary disease	0.000716	0.00922	CcSEcCtD
Flunitrazepam—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000706	0.00908	CcSEcCtD
Flunitrazepam—Hiccups—Prednisolone—chronic obstructive pulmonary disease	0.000698	0.00898	CcSEcCtD
Flunitrazepam—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000693	0.00892	CcSEcCtD
Flunitrazepam—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000681	0.00876	CcSEcCtD
Flunitrazepam—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00068	0.00875	CcSEcCtD
Flunitrazepam—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.000652	0.00839	CcSEcCtD
Flunitrazepam—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00065	0.00836	CcSEcCtD
Flunitrazepam—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000638	0.0082	CcSEcCtD
Flunitrazepam—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000631	0.00811	CcSEcCtD
Flunitrazepam—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000628	0.00808	CcSEcCtD
Flunitrazepam—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000599	0.0077	CcSEcCtD
Flunitrazepam—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00059	0.00758	CcSEcCtD
Flunitrazepam—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000581	0.00748	CcSEcCtD
Flunitrazepam—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000571	0.00735	CcSEcCtD
Flunitrazepam—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000571	0.00734	CcSEcCtD
Flunitrazepam—Acenocoumarol—CYP1A2—chronic obstructive pulmonary disease	0.000568	0.386	CrCbGaD
Flunitrazepam—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000567	0.0073	CcSEcCtD
Flunitrazepam—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000564	0.00726	CcSEcCtD
Flunitrazepam—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000556	0.00715	CcSEcCtD
Flunitrazepam—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000528	0.00679	CcSEcCtD
Flunitrazepam—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000528	0.00679	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000523	0.00672	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000523	0.00672	CcSEcCtD
Flunitrazepam—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000518	0.00666	CcSEcCtD
Flunitrazepam—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000518	0.00666	CcSEcCtD
Flunitrazepam—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000517	0.00665	CcSEcCtD
Flunitrazepam—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000515	0.00662	CcSEcCtD
Flunitrazepam—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000515	0.00662	CcSEcCtD
Flunitrazepam—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000508	0.00653	CcSEcCtD
Flunitrazepam—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000508	0.00653	CcSEcCtD
Flunitrazepam—Hiccups—Prednisone—chronic obstructive pulmonary disease	0.000507	0.00652	CcSEcCtD
Flunitrazepam—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000507	0.00652	CcSEcCtD
Flunitrazepam—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000504	0.00648	CcSEcCtD
Flunitrazepam—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000498	0.00641	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000493	0.00635	CcSEcCtD
Flunitrazepam—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000489	0.00629	CcSEcCtD
Flunitrazepam—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000486	0.00625	CcSEcCtD
Flunitrazepam—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00048	0.00617	CcSEcCtD
Flunitrazepam—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000478	0.00615	CcSEcCtD
Flunitrazepam—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000478	0.00615	CcSEcCtD
Flunitrazepam—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000474	0.00609	CcSEcCtD
Flunitrazepam—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000474	0.00609	CcSEcCtD
Flunitrazepam—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000469	0.00603	CcSEcCtD
Flunitrazepam—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000469	0.00603	CcSEcCtD
Flunitrazepam—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000468	0.00602	CcSEcCtD
Flunitrazepam—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000451	0.0058	CcSEcCtD
Flunitrazepam—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000449	0.00577	CcSEcCtD
Flunitrazepam—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000449	0.00577	CcSEcCtD
Flunitrazepam—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000447	0.00575	CcSEcCtD
Flunitrazepam—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000447	0.00575	CcSEcCtD
Flunitrazepam—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000443	0.0057	CcSEcCtD
Flunitrazepam—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00043	0.00553	CcSEcCtD
Flunitrazepam—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00043	0.00553	CcSEcCtD
Flunitrazepam—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000424	0.00545	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00042	0.0054	CcSEcCtD
Flunitrazepam—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000409	0.00526	CcSEcCtD
Flunitrazepam—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000409	0.00526	CcSEcCtD
Flunitrazepam—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000406	0.00522	CcSEcCtD
Flunitrazepam—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.0004	0.00515	CcSEcCtD
Flunitrazepam—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000399	0.00514	CcSEcCtD
Flunitrazepam—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000396	0.0051	CcSEcCtD
Flunitrazepam—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000396	0.0051	CcSEcCtD
Flunitrazepam—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000392	0.00504	CcSEcCtD
Flunitrazepam—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000388	0.00499	CcSEcCtD
Flunitrazepam—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.00496	CcSEcCtD
Flunitrazepam—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000381	0.0049	CcSEcCtD
Flunitrazepam—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00038	0.00489	CcSEcCtD
Flunitrazepam—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000379	0.00487	CcSEcCtD
Flunitrazepam—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000379	0.00487	CcSEcCtD
Flunitrazepam—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000378	0.00487	CcSEcCtD
Flunitrazepam—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000377	0.00485	CcSEcCtD
Flunitrazepam—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000374	0.00481	CcSEcCtD
Flunitrazepam—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000359	0.00462	CcSEcCtD
Flunitrazepam—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000359	0.00462	CcSEcCtD
Flunitrazepam—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000359	0.00462	CcSEcCtD
Flunitrazepam—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000358	0.0046	CcSEcCtD
Flunitrazepam—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000357	0.00459	CcSEcCtD
Flunitrazepam—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000351	0.00452	CcSEcCtD
Flunitrazepam—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00033	0.00424	CcSEcCtD
Flunitrazepam—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.00424	CcSEcCtD
Flunitrazepam—Acenocoumarol—ALB—chronic obstructive pulmonary disease	0.000328	0.223	CrCbGaD
Flunitrazepam—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000325	0.00418	CcSEcCtD
Flunitrazepam—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000323	0.00416	CcSEcCtD
Flunitrazepam—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.00401	CcSEcCtD
Flunitrazepam—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000304	0.00391	CcSEcCtD
Flunitrazepam—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000304	0.00391	CcSEcCtD
Flunitrazepam—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000298	0.00383	CcSEcCtD
Flunitrazepam—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00029	0.00373	CcSEcCtD
Flunitrazepam—Rash—Formoterol—chronic obstructive pulmonary disease	0.00029	0.00373	CcSEcCtD
Flunitrazepam—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00029	0.00373	CcSEcCtD
Flunitrazepam—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00029	0.00373	CcSEcCtD
Flunitrazepam—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000288	0.0037	CcSEcCtD
Flunitrazepam—Headache—Formoterol—chronic obstructive pulmonary disease	0.000288	0.0037	CcSEcCtD
Flunitrazepam—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000287	0.00369	CcSEcCtD
Flunitrazepam—Rash—Montelukast—chronic obstructive pulmonary disease	0.000284	0.00365	CcSEcCtD
Flunitrazepam—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000284	0.00365	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000283	0.00364	CcSEcCtD
Flunitrazepam—Headache—Montelukast—chronic obstructive pulmonary disease	0.000282	0.00363	CcSEcCtD
Flunitrazepam—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000279	0.00359	CcSEcCtD
Flunitrazepam—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000275	0.00354	CcSEcCtD
Flunitrazepam—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000274	0.00352	CcSEcCtD
Flunitrazepam—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000273	0.00352	CcSEcCtD
Flunitrazepam—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000272	0.0035	CcSEcCtD
Flunitrazepam—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000257	0.0033	CcSEcCtD
Flunitrazepam—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000253	0.00326	CcSEcCtD
Flunitrazepam—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000243	0.00313	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000241	0.0031	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000206	0.00265	CcSEcCtD
Flunitrazepam—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000205	0.00264	CcSEcCtD
Flunitrazepam—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000204	0.00262	CcSEcCtD
Flunitrazepam—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000203	0.00261	CcSEcCtD
Flunitrazepam—Malaise—Prednisone—chronic obstructive pulmonary disease	0.0002	0.00257	CcSEcCtD
Flunitrazepam—Ketazolam—ALB—chronic obstructive pulmonary disease	0.000196	0.133	CrCbGaD
Flunitrazepam—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000188	0.00242	CcSEcCtD
Flunitrazepam—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000186	0.0024	CcSEcCtD
Flunitrazepam—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000177	0.00227	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000175	0.00225	CcSEcCtD
Flunitrazepam—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.00212	CcSEcCtD
Flunitrazepam—Clonazepam—ALB—chronic obstructive pulmonary disease	0.000158	0.108	CrCbGaD
Flunitrazepam—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.00202	CcSEcCtD
Flunitrazepam—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.00202	CcSEcCtD
Flunitrazepam—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000156	0.00201	CcSEcCtD
Flunitrazepam—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.00201	CcSEcCtD
Flunitrazepam—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000149	0.00192	CcSEcCtD
Flunitrazepam—Diazepam—CYP1A2—chronic obstructive pulmonary disease	0.00014	0.0954	CrCbGaD
Flunitrazepam—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00167	CcSEcCtD
Flunitrazepam—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00012	0.00154	CcSEcCtD
Flunitrazepam—Rash—Prednisone—chronic obstructive pulmonary disease	0.000114	0.00147	CcSEcCtD
Flunitrazepam—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000114	0.00147	CcSEcCtD
Flunitrazepam—Headache—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00146	CcSEcCtD
Flunitrazepam—Diazepam—ALB—chronic obstructive pulmonary disease	8.11e-05	0.0551	CrCbGaD
Flunitrazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	7.38e-05	0.000949	CbGpPWpGaD
Flunitrazepam—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	7.28e-05	0.000937	CbGpPWpGaD
Flunitrazepam—CYP2A6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.23e-05	0.00093	CbGpPWpGaD
Flunitrazepam—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.22e-05	0.00093	CbGpPWpGaD
Flunitrazepam—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.99e-05	0.000899	CbGpPWpGaD
Flunitrazepam—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.94e-05	0.000894	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.89e-05	0.000887	CbGpPWpGaD
Flunitrazepam—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.85e-05	0.000882	CbGpPWpGaD
Flunitrazepam—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.85e-05	0.000881	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.75e-05	0.000869	CbGpPWpGaD
Flunitrazepam—CYP2A6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.64e-05	0.000854	CbGpPWpGaD
Flunitrazepam—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	6.63e-05	0.000853	CbGpPWpGaD
Flunitrazepam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.59e-05	0.000848	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—APIP—chronic obstructive pulmonary disease	6.57e-05	0.000845	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.36e-05	0.000818	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.3e-05	0.00081	CbGpPWpGaD
Flunitrazepam—CYP2A6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.29e-05	0.00081	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.28e-05	0.000808	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—GC—chronic obstructive pulmonary disease	6.13e-05	0.000788	CbGpPWpGaD
Flunitrazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	5.98e-05	0.000769	CbGpPWpGaD
Flunitrazepam—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	5.87e-05	0.000755	CbGpPWpGaD
Flunitrazepam—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.83e-05	0.00075	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.79e-05	0.000746	CbGpPWpGaD
Flunitrazepam—UGT1A3—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	5.79e-05	0.000745	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.75e-05	0.00074	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.73e-05	0.000737	CbGpPWpGaD
Flunitrazepam—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.71e-05	0.000735	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.7e-05	0.000733	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.63e-05	0.000725	CbGpPWpGaD
Flunitrazepam—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.63e-05	0.000724	CbGpPWpGaD
Flunitrazepam—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	5.39e-05	0.000694	CbGpPWpGaD
Flunitrazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.36e-05	0.00069	CbGpPWpGaD
Flunitrazepam—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.36e-05	0.000689	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.35e-05	0.000689	CbGpPWpGaD
Flunitrazepam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.29e-05	0.000681	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.28e-05	0.00068	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.28e-05	0.00068	CbGpPWpGaD
Flunitrazepam—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.25e-05	0.000675	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.21e-05	0.00067	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—GC—chronic obstructive pulmonary disease	5.21e-05	0.00067	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.17e-05	0.000666	CbGpPWpGaD
Flunitrazepam—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.08e-05	0.000654	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—APIP—chronic obstructive pulmonary disease	5.06e-05	0.000652	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.01e-05	0.000645	CbGpPWpGaD
Flunitrazepam—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.97e-05	0.00064	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.95e-05	0.000637	CbGpPWpGaD
Flunitrazepam—UGT2B7—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	4.93e-05	0.000634	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.91e-05	0.000631	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.89e-05	0.00063	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.84e-05	0.000623	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.82e-05	0.00062	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	4.75e-05	0.000611	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.75e-05	0.000611	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	4.66e-05	0.000599	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	4.47e-05	0.000575	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.47e-05	0.000575	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.41e-05	0.000567	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.35e-05	0.00056	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.34e-05	0.000559	CbGpPWpGaD
Flunitrazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.34e-05	0.000559	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.28e-05	0.00055	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—GC—chronic obstructive pulmonary disease	4.23e-05	0.000545	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.22e-05	0.000543	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	4.09e-05	0.000526	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.07e-05	0.000524	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.05e-05	0.000521	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.02e-05	0.000518	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.02e-05	0.000517	CbGpPWpGaD
Flunitrazepam—UGT1A1—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	4e-05	0.000515	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	4e-05	0.000515	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.99e-05	0.000514	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.96e-05	0.00051	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.94e-05	0.000506	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.84e-05	0.000494	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.82e-05	0.000492	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.78e-05	0.000487	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3.78e-05	0.000487	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.78e-05	0.000486	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.75e-05	0.000483	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	3.69e-05	0.000475	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.69e-05	0.000475	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.68e-05	0.000474	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.64e-05	0.000468	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.62e-05	0.000466	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.62e-05	0.000466	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.62e-05	0.000466	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.5e-05	0.00045	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.48e-05	0.000448	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.45e-05	0.000444	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.45e-05	0.000444	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.45e-05	0.000444	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.43e-05	0.000442	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.39e-05	0.000436	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.35e-05	0.000432	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.35e-05	0.000431	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—GCLC—chronic obstructive pulmonary disease	3.31e-05	0.000426	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—GC—chronic obstructive pulmonary disease	3.26e-05	0.00042	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.24e-05	0.000417	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.18e-05	0.000409	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.15e-05	0.000406	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.13e-05	0.000403	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.11e-05	0.0004	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.09e-05	0.000397	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.09e-05	0.000397	CbGpPWpGaD
Flunitrazepam—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	3.09e-05	0.000397	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.03e-05	0.00039	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—CTGF—chronic obstructive pulmonary disease	3.02e-05	0.000388	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.99e-05	0.000385	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.95e-05	0.00038	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.85e-05	0.000366	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.82e-05	0.000362	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—GCLC—chronic obstructive pulmonary disease	2.81e-05	0.000362	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.78e-05	0.000358	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.71e-05	0.000348	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.65e-05	0.000341	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.65e-05	0.000341	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	2.63e-05	0.000339	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.62e-05	0.000337	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.61e-05	0.000336	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	2.58e-05	0.000332	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.57e-05	0.00033	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—CTGF—chronic obstructive pulmonary disease	2.57e-05	0.00033	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.53e-05	0.000326	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.45e-05	0.000315	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.43e-05	0.000313	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.41e-05	0.00031	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.4e-05	0.000309	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.4e-05	0.000309	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.36e-05	0.000304	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.32e-05	0.000299	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.31e-05	0.000298	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.31e-05	0.000297	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.29e-05	0.000294	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.29e-05	0.000294	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.28e-05	0.000293	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.25e-05	0.00029	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.21e-05	0.000285	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.2e-05	0.000283	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.17e-05	0.00028	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.13e-05	0.000274	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.09e-05	0.000268	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.05e-05	0.000263	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.03e-05	0.000261	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.02e-05	0.00026	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.01e-05	0.000258	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.99e-05	0.000256	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.97e-05	0.000254	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.95e-05	0.00025	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.92e-05	0.000247	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.86e-05	0.00024	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.86e-05	0.000239	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.85e-05	0.000239	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.85e-05	0.000238	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.85e-05	0.000238	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.81e-05	0.000233	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.81e-05	0.000233	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.78e-05	0.000229	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.76e-05	0.000227	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.72e-05	0.000221	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.72e-05	0.000221	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.69e-05	0.000217	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.61e-05	0.000207	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.6e-05	0.000206	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.59e-05	0.000205	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.58e-05	0.000203	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.55e-05	0.000199	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.48e-05	0.000191	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.47e-05	0.00019	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.47e-05	0.00019	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.44e-05	0.000185	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.44e-05	0.000185	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.42e-05	0.000183	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.41e-05	0.000181	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.4e-05	0.00018	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.39e-05	0.000179	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—ALB—chronic obstructive pulmonary disease	1.37e-05	0.000177	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.34e-05	0.000173	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—NOS3—chronic obstructive pulmonary disease	1.31e-05	0.000169	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.3e-05	0.000167	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.27e-05	0.000164	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.24e-05	0.000159	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.23e-05	0.000158	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.22e-05	0.000157	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.2e-05	0.000154	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.2e-05	0.000154	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.17e-05	0.000151	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—ALB—chronic obstructive pulmonary disease	1.17e-05	0.00015	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.15e-05	0.000148	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.14e-05	0.000146	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.12e-05	0.000144	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.11e-05	0.000143	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.09e-05	0.00014	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.08e-05	0.000139	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.07e-05	0.000138	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1e-05	0.000129	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.97e-06	0.000128	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.91e-06	0.000128	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.83e-06	0.000127	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	9.8e-06	0.000126	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	9.8e-06	0.000126	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.76e-06	0.000126	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.63e-06	0.000124	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—ALB—chronic obstructive pulmonary disease	9.49e-06	0.000122	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.16e-06	0.000118	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.13e-06	0.000118	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.08e-06	0.000117	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.03e-06	0.000116	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.97e-06	0.000115	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	8.94e-06	0.000115	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.68e-06	0.000112	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.51e-06	0.000109	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.47e-06	0.000109	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	8.37e-06	0.000108	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.24e-06	0.000106	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.8e-06	0.0001	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.64e-06	9.83e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.53e-06	9.69e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.43e-06	9.56e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	7.32e-06	9.42e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	7e-06	9.01e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.92e-06	8.91e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.87e-06	8.84e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.77e-06	8.72e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.56e-06	8.45e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.54e-06	8.41e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.46e-06	8.31e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.31e-06	8.12e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.98e-06	7.7e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	5.9e-06	7.6e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.9e-06	7.59e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.87e-06	7.55e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.79e-06	7.45e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	5.78e-06	7.44e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.65e-06	7.27e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.53e-06	7.12e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.43e-06	6.99e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.39e-06	6.94e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.11e-06	6.58e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.53e-06	5.83e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.47e-06	5.75e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	4.46e-06	5.74e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.27e-06	5.49e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.16e-06	5.36e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	4.07e-06	5.23e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.95e-06	5.08e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.89e-06	5.01e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.48e-06	4.47e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.32e-06	4.28e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.68e-06	3.45e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.57e-06	3.3e-05	CbGpPWpGaD
